HIV-associated lung infections and complications in the era of combination antiretroviral therapy

Kristina Crothers, Bruce W. Thompson, Kathryn Burkhardt, Alison Morris, Sonia C. Flores, Philip T. Diaz, Richard E Chaisson, Gregory D Kirk, William N. Rom, Laurence Huang

Research output: Contribution to journalArticle

Abstract

The spectrum of lung diseases associated with HIV is broad, and many infectious and noninfectious complications of HIV infection have been recognized. The nature and prevalence of lung complications have not been fully characterized since the Pulmonary Complications of HIV Infection Study more than 15 years ago, before antiretroviral therapy (ART) increased life expectancy. Our understanding of the global epidemiology of these diseases in the current ART era is limited, and the mechanisms for the increases in the noninfectious conditions, in particular, are not well understood. The Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV) Study (ClinicalTrials.gov number NCT00933595) is a collaborative multi-R01 consortium of research projects established by the National Heart, Lung, and Blood Institute to examine a diverse range of infectious and noninfectious pulmonary diseases in HIV-infected persons. This article reviews our current state of knowledge of the impact of HIV on lung health and the development of pulmonary diseases, and highlights ongoing research within the Lung HIV Study.

Original languageEnglish (US)
Pages (from-to)275-281
Number of pages7
JournalProceedings of the American Thoracic Society
Volume8
Issue number3
DOIs
StatePublished - Jun 1 2011

Fingerprint

HIV
Lung
Infection
Lung Diseases
HIV Infections
Therapeutics
National Heart, Lung, and Blood Institute (U.S.)
Life Expectancy
Research
Longitudinal Studies
Epidemiology
Health

Keywords

  • HIV/AIDS
  • Pulmonary complications
  • Pulmonary infections
  • Smoking

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Crothers, K., Thompson, B. W., Burkhardt, K., Morris, A., Flores, S. C., Diaz, P. T., ... Huang, L. (2011). HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proceedings of the American Thoracic Society, 8(3), 275-281. https://doi.org/10.1513/pats.201009-059WR

HIV-associated lung infections and complications in the era of combination antiretroviral therapy. / Crothers, Kristina; Thompson, Bruce W.; Burkhardt, Kathryn; Morris, Alison; Flores, Sonia C.; Diaz, Philip T.; Chaisson, Richard E; Kirk, Gregory D; Rom, William N.; Huang, Laurence.

In: Proceedings of the American Thoracic Society, Vol. 8, No. 3, 01.06.2011, p. 275-281.

Research output: Contribution to journalArticle

Crothers, Kristina ; Thompson, Bruce W. ; Burkhardt, Kathryn ; Morris, Alison ; Flores, Sonia C. ; Diaz, Philip T. ; Chaisson, Richard E ; Kirk, Gregory D ; Rom, William N. ; Huang, Laurence. / HIV-associated lung infections and complications in the era of combination antiretroviral therapy. In: Proceedings of the American Thoracic Society. 2011 ; Vol. 8, No. 3. pp. 275-281.
@article{63e5bb7a6a2a4b71a0376b2d6d972cd5,
title = "HIV-associated lung infections and complications in the era of combination antiretroviral therapy",
abstract = "The spectrum of lung diseases associated with HIV is broad, and many infectious and noninfectious complications of HIV infection have been recognized. The nature and prevalence of lung complications have not been fully characterized since the Pulmonary Complications of HIV Infection Study more than 15 years ago, before antiretroviral therapy (ART) increased life expectancy. Our understanding of the global epidemiology of these diseases in the current ART era is limited, and the mechanisms for the increases in the noninfectious conditions, in particular, are not well understood. The Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV) Study (ClinicalTrials.gov number NCT00933595) is a collaborative multi-R01 consortium of research projects established by the National Heart, Lung, and Blood Institute to examine a diverse range of infectious and noninfectious pulmonary diseases in HIV-infected persons. This article reviews our current state of knowledge of the impact of HIV on lung health and the development of pulmonary diseases, and highlights ongoing research within the Lung HIV Study.",
keywords = "HIV/AIDS, Pulmonary complications, Pulmonary infections, Smoking",
author = "Kristina Crothers and Thompson, {Bruce W.} and Kathryn Burkhardt and Alison Morris and Flores, {Sonia C.} and Diaz, {Philip T.} and Chaisson, {Richard E} and Kirk, {Gregory D} and Rom, {William N.} and Laurence Huang",
year = "2011",
month = "6",
day = "1",
doi = "10.1513/pats.201009-059WR",
language = "English (US)",
volume = "8",
pages = "275--281",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - HIV-associated lung infections and complications in the era of combination antiretroviral therapy

AU - Crothers, Kristina

AU - Thompson, Bruce W.

AU - Burkhardt, Kathryn

AU - Morris, Alison

AU - Flores, Sonia C.

AU - Diaz, Philip T.

AU - Chaisson, Richard E

AU - Kirk, Gregory D

AU - Rom, William N.

AU - Huang, Laurence

PY - 2011/6/1

Y1 - 2011/6/1

N2 - The spectrum of lung diseases associated with HIV is broad, and many infectious and noninfectious complications of HIV infection have been recognized. The nature and prevalence of lung complications have not been fully characterized since the Pulmonary Complications of HIV Infection Study more than 15 years ago, before antiretroviral therapy (ART) increased life expectancy. Our understanding of the global epidemiology of these diseases in the current ART era is limited, and the mechanisms for the increases in the noninfectious conditions, in particular, are not well understood. The Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV) Study (ClinicalTrials.gov number NCT00933595) is a collaborative multi-R01 consortium of research projects established by the National Heart, Lung, and Blood Institute to examine a diverse range of infectious and noninfectious pulmonary diseases in HIV-infected persons. This article reviews our current state of knowledge of the impact of HIV on lung health and the development of pulmonary diseases, and highlights ongoing research within the Lung HIV Study.

AB - The spectrum of lung diseases associated with HIV is broad, and many infectious and noninfectious complications of HIV infection have been recognized. The nature and prevalence of lung complications have not been fully characterized since the Pulmonary Complications of HIV Infection Study more than 15 years ago, before antiretroviral therapy (ART) increased life expectancy. Our understanding of the global epidemiology of these diseases in the current ART era is limited, and the mechanisms for the increases in the noninfectious conditions, in particular, are not well understood. The Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV) Study (ClinicalTrials.gov number NCT00933595) is a collaborative multi-R01 consortium of research projects established by the National Heart, Lung, and Blood Institute to examine a diverse range of infectious and noninfectious pulmonary diseases in HIV-infected persons. This article reviews our current state of knowledge of the impact of HIV on lung health and the development of pulmonary diseases, and highlights ongoing research within the Lung HIV Study.

KW - HIV/AIDS

KW - Pulmonary complications

KW - Pulmonary infections

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=80051729388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051729388&partnerID=8YFLogxK

U2 - 10.1513/pats.201009-059WR

DO - 10.1513/pats.201009-059WR

M3 - Article

VL - 8

SP - 275

EP - 281

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 3

ER -